Healthcare provider profile · identity verified

Kate E Skipton, MD

Family Practice · WILLIAMSPORT, PA · NPI 1548607500

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	459	135
Atorvastatin Calcium	Atorvastatin Calcium	393	130
Rosuvastatin Calcium	Rosuvastatin Calcium	352	109
Lisinopril	Lisinopril	317	85
Gabapentin	Gabapentin	247	57
Amlodipine Besylate	Amlodipine Besylate	238	83
Omeprazole	Omeprazole	194	54
Pantoprazole Sodium	Pantoprazole Sodium	174	60
Losartan Potassium	Losartan Potassium	166	53
Metoprolol Succinate	Metoprolol Succinate	142	38
Escitalopram Oxalate	Escitalopram Oxalate	132	45
Pravastatin Sodium	Pravastatin Sodium	123	38
Sertraline Hcl	Sertraline Hcl	121	44
Zolpidem Tartrate	Zolpidem Tartrate	119	21
Metformin Hcl	Metformin Hcl	115	35
Albuterol Sulfate Hfa	Albuterol Sulfate	111	46
Hydrochlorothiazide	Hydrochlorothiazide	111	42
Ozempic	Semaglutide	107	14
Famotidine	Famotidine	97	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	26
Chlorthalidone	Chlorthalidone	88	27
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	87	17
Metoprolol Tartrate	Metoprolol Tartrate	86	23
Simvastatin	Simvastatin	83	25
Metformin Hcl Er	Metformin Hcl	79	27
Fluoxetine Hcl	Fluoxetine Hcl	73	21
Carvedilol	Carvedilol	72	25
Warfarin Sodium	Warfarin Sodium	71	14
Eliquis	Apixaban	69	20
Fluticasone Propionate	Fluticasone Propionate	68	31
Alendronate Sodium	Alendronate Sodium	66	25
Potassium Chloride	Potassium Chloride	66	20
Bupropion Xl	Bupropion Hcl	61	24
Duloxetine Hcl	Duloxetine Hcl	60	19
Alprazolam	Alprazolam	57	14
Sumatriptan Succinate	Sumatriptan Succinate	57	suppressed
Oxycodone Hcl	Oxycodone Hcl	55	12
Synthroid	Levothyroxine Sodium	55	16
Venlafaxine Hcl Er	Venlafaxine Hcl	55	13
Irbesartan	Irbesartan	53	17
Atenolol	Atenolol	52	16
Hydroxyzine Hcl	Hydroxyzine Hcl	50	19
Trazodone Hcl	Trazodone Hcl	50	18
Allopurinol	Allopurinol	46	14
Clonazepam	Clonazepam	42	suppressed
Spironolactone	Spironolactone	40	12
Pregabalin	Pregabalin	39	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Torsemide	Torsemide	36	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Meloxicam	Meloxicam	34	15
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	32	13
Glipizide Er	Glipizide	31	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Furosemide	Furosemide	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	11
Lovastatin	Lovastatin	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Ciclopirox	Ciclopirox	25	suppressed
Prednisone	Prednisone	25	19
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	21
Amitriptyline Hcl	Amitriptyline Hcl	23	11
Enalapril Maleate	Enalapril Maleate	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Diazepam	Diazepam	17	suppressed
Finasteride	Finasteride	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Zaleplon	Zaleplon	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Felodipine Er	Felodipine	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cephalexin	Cephalexin	13	13
Creon	Lipase/Protease/Amylase	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Valsartan	Valsartan	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Glipizide	Glipizide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Estradiol	Estradiol	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Primidone	Primidone	11	suppressed
Ramipril	Ramipril	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error